Product Introduction
Malnate 150 mg Injection is an antimalarial medication manufactured by FDC Limited. It contains Artesunate (150 mg) as the active ingredient and is used for the management of severe malaria caused by Plasmodium falciparum. This injection is administered under the supervision of a healthcare professional. ​
Uses
Malnate 150 mg Injection is prescribed for:​
- Severe falciparum malaria
- Cerebral malaria
- Malaria complicated by organ failure​
Benefits
- Rapid reduction in parasitic load, leading to quicker clinical improvement.
- Effective in severe cases, including those with neurological involvement.
- Suitable for patients unable to take oral medications.​
Composition
Each 2 ml vial contains:​
- Artesunate – 150 mg​
Side Effects
Common side effects may include:​
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)​
If any of these side effects persist or worsen, consult your healthcare provider. ​
Safety Advice
- For intravenous or intramuscular use only; administered by a healthcare professional.
- Avoid self-administration.
- Monitor for side effects during and after administration.
- Consult your doctor if you are pregnant, breastfeeding, or have liver or kidney problems.
- Alcohol consumption should be avoided during treatment.
